Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis

Comparison of neoadjuvant immunotherapy versus routine neoadjuvant therapy for patients with locally advanced esophageal cancer: A systematic review and meta-analysis

BackgroundThe neoadjuvant use of immune checkpoint inhibitor combined with chemotherapy (nICT) or chemoradiotherapy (nICRT) in locally advanced esophageal cancer (EC) is currently an area of active ongoing research. Therefore, we carried out a comprehensive meta-analysis to compare the efficacy and...

Full description

Bibliographic Details
Main Authors: Hao Qin, Futao Liu, Yaozhong Zhang, Yuxiang Liang, Yuan Mi, Fan Yu, Haidi Xu, Kuankuan Li, Chenxi Lin, Lei Li, Ziqiang Tian, Lei Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
esophageal cancer
neoadjuvant
immune checkpoint inhibitor
chemotherapy
chemoradiotherapy
pathological complete response
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1108213/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1108213/full

Similar Items